🇪🇺 Venetoclax; Rituximab in European Union

Venetoclax; Rituximab (venetoclax-rituximab) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Venetoclax; Rituximab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Venetoclax; Rituximab approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Venetoclax; Rituximab in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.